Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: A prospective randomized controlled study

Journal of Physical Therapy Science

Volumn 27, Issue 7, 2015, Pages 2293-2297

  Turan, Volkan ^a   Mutlu, Ebru Kaya ^b   Solmaz, Ulas ^a   Ekin, Atalay ^a   Tosun, Ozge ^c   Tosun, Gokhan ^a   Mat, Emre ^a   Gezer, Cenk ^a   Malkoc, Mehtap ^c  

^a Tepecik Training and Research Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Exercise; Non overweight; Polycystic ovary syndrome

Indexed keywords

EID: 84937945632     PISSN: 09155287     EISSN: None     Source Type: Journal    
DOI: 10.1589/jpts.27.2293     Document Type: Article

References (29)

1. Ehrmann DA: Polycystic ovary syndrome. N Engl J Med, 2005, 352: 1223-1236. [Medline] [CrossRef]
2. Sheehan MT: Polycystic ovarian syndrome: diagnosis and management. Clin Med Res, 2004, 2: 13-27. [Medline] [CrossRef]
3. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, et al.: Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab, 2007, 18: 280-285. [Medline] [CrossRef]
4. Moran LJ, Lombard CB, Lim S, et al.: Polycystic ovary syndrome and weight management. Womens Health (Lond Engl), 2010, 6: 271-283. [Medline] [CrossRef]
5. Thomson RL, Buckley JD, Noakes M, et al.: The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2008, 93: 3373-3380. [Medline] [CrossRef]
6. Lee HC, Heo T: Effects of exercise therapy on blood lipids of obese women. J Phys Ther Sci, 2014, 26: 1675-1677. [Medline] [CrossRef]
7. Tamura T, Kida K, Seki T, et al.: Study of the relationship between exercise therapy and diet therapy in type 2 diabetes mellitus patients. J Phys Ther Sci, 2011, 23: 485-488. [CrossRef]
8. Li L, Chen X, He Z, et al.: Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. J Pediatr Adolesc Gynecol, 2012, 25: 390-395. [Medline] [CrossRef]
9. Thomson RL, Buckley JD, Moran LJ, et al.: Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. BJOG, 2009, 116: 1242-1250. [Medline] [CrossRef]
10. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 2004, 81: 19-25. [CrossRef]
11. Carmina E, Orio F, Palomba S, et al.: Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters. Fertil Steril, 2005, 84: 413-419. [Medline] [CrossRef]
12. Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab, 1961, 21: 1440-1447. [Medline] [CrossRef]
13. Kervio G, Carre F, Ville NS: Reliability and intensity of the six-minute walk test in healthy elderly subjects. Med Sci Sports Exerc, 2003, 35: 169-174. [Medline] [CrossRef]
14. Saglam M, Arikan H, Savci S, et al.: International physical activity questionnaire: reliability and validity of the Turkish version. Percept Mot Skills, 2010, 111: 278-284. [Medline] [CrossRef]
15. Borg G: Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med, 1970, 2: 92-98. [Medline]
16. Robertson RJ, Goss FL, Rutkowski J, et al.: Concurrent validation of the OMNI perceived exertion scale for resistance exercise. Med Sci Sports Exerc, 2003, 35: 333-341. [Medline] [CrossRef]
17. Lee Y, Jun I, Ju S: Impact of home exercise training on patients with acute myocardial infarction. J Phys Ther Sci, 2012, 24: 743-745. [CrossRef]
18. Kim DY, Seo BD, Kim DJ: Effect of walking exercise on changes in cardiorespiratory fitness, metabolic syndrome markers, and high-molecularweight adiponectin in obese middle-aged women. J Phys Ther Sci, 2014, 26: 1723-1727. [Medline] [CrossRef]
19. Yagura C, Takamura N, Goto Y, et al.: Cardiorespiratory fitness and metabolic markers in healthy young adult men. J Phys Ther Sci, 2011, 23: 845-849. [CrossRef]
20. Fux Otta C, Wior M, Iraci GS, et al.: Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial. Gynecol Endocrinol, 2010, 26: 173-178. [Medline] [Cross-Ref]
21. Harborne L, Fleming R, Lyall H, et al.: Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet, 2003, 361: 1894-1901. [Medline] [CrossRef]
22. Nestler JE: Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med, 2008, 358: 47-54. [Medline] [CrossRef]
23. Açbay O, Gündoğdu S: Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril, 1996, 65: 946-949. [Medline]
24. Ehrmann DA, Cavaghan MK, Imperial J, et al.: Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1997, 82: 524-530. [Medline]
25. Orio F, Giallauria F, Palomba S, et al.: Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women. Clin Endocrinol (Oxf), 2008, 68: 976-981. [Medline] [CrossRef]
26. Giallauria F, Palomba S, Maresca L, et al.: Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf), 2008, 69: 792-798. [Medline] [CrossRef]
27. Vigorito C, Giallauria F, Palomba S, et al.: Beneficial effects of a threemonth structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2007, 92: 1379-1384. [Medline] [CrossRef]
28. Liao LM, Nesic J, Chadwick PM, et al.: Exercise and body image distress in overweight and obese women with polycystic ovary syndrome: a pilot investigation. Gynecol Endocrinol, 2008, 24: 555-561. [Medline] [Cross-Ref]
29. Panidis D, Farmakiotis D, Rousso D, et al.: Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Fertil Steril, 2008, 89: 899-906. [Medline] [CrossRef]